Capital Cell Shortlisted for UK Business Angels Association Investment Award

Capital Cell, reportedly Europe’s first equity crowdfunding platform specializing in life science, has been shortlisted for the Best International Growth Business award at the UK Business Angels Association Investment Awards 2017. Capital Cell has been trading in Spain for just over 2 years, successfully closing 14 life science crowdfunding campaigns, including the country’s largest life science crowdfunding campaign of over €1.2M, for Bionure, a potential therapeutic cure for MS.

“We are absolutely thrilled that Capital Cell has been recognised so early on in its expansion into the UK, ” shared UK Director Laura Ferguson. ‘The reception to our arrival has been overwhelmingly positive from players throughout the life science ecosystem, including specialised investors such as Angels in MedCity, with whom we are collaborating closely, as well as the NHS innovation, science parks and startup incubators. It’s wonderful to have that traction formally recognised.”

Scaling up from its Barcelona-based platform, Capital Cell UK launched earlier in June with a range of companies solving unmet needs from malaria control to female fertility enhancement and autoimmune disease.

“Capital Cell has already proven itself as a platform for early stage investment in a very challenging environment, so we are extremely excited about scaling up in the UK, which is a global leader not only in life science innovation but also in equity crowdfunding,” added Capital Cell Chairman and lead investor Ian Tomlinson. “As an investment area, life science has the potential for both huge social impact and significant financial returns and the companies listed on Capital Cell are all trying to solve a major unmet medical need. By opening up these investment opportunities to more people we hope to be able to help the UK remain at the cutting edge of life science commercialisation.”



Sponsored Links by DQ Promote

 

 

Disclosure Quest

Reg A - Form 1-A Filings Beta

Beta. Initial Form 1-A only. Target raise is the stated Amount to be Raised, totaled. Compared with the same dates one year earlier.

YTD: Jan 1, 2026 - Nov 18, 2026 vs Jan 1, 2025 - Nov 18, 2025

Share this graph
Number of Filings138Prior 131 +5.3%
Target Raise, Total$3.49BPrior $3.62B -3.7%
This YTDYear priorChange
Filings 138 131 +5.3%
Target raise $3.49B $3.62B -3.7%

Sponsored by the Crowded Media Group the leading digital news service covering the global Fintech Industry, including digital assets, crowdfunding, tokenization, and other innovations in capital markets. email us @CrowdfundInside

Source: DisclosureQuest. Initial Form 1-A only.

Created by Crowded Media Group

This display counts initial Form 1-A filings only. It does not represent subsequent filings, including Form 1-A/A amendments or Form 1-A POS post-qualification updates filed by the issuer. Amounts are the stated Amount to be Raised on the initial filing, not capital raised and not amounts revised in later filings.

0 0 votes
Article Rating
Subscribe
Notify of
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Newest
Oldest Most Voted
 
0
Would love your thoughts, please comment.x
()
x
Send this to a friend